is glp 1 a controlled substance Trends in the Development of GLP-1 Receptor Agonists The Ultimate Guide to GLP-1:

Bjarnason NH, Henriksen EE, Alexandersen P, et al

Dermatology practical & conceptual , 12 (1)

Do not view it as a fat-loss shortcut

Lilly is expanding the category itself, drawing in new patients in addition to market share gains from injectable rivals

The expiry of the semaglutide patent, the molecule in Novo Nordisk's weight-loss drugs Wegovy and Ozempic, in India in March, has attracted many generics majors to tap one of the fastest-growing segments globally

J Hepatol 42(6):928940 Petit JM, Cercueil JP, Loffroy R, Denimal D, Bouillet B, Fourmont C, Chevallier O, Duvillard L, Vergs B (2017) Effect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes: the Lira-NAFLD Study